Category Archives: Regulations

Portugal’s Challenge to the UK Tobacco Ban: A New Test for Post-Brexit Regulatory Sovereignty

Portugal’s recent accusation that the United Kingdom’s proposed tobacco ban may violate post-Brexit legal commitments has introduced a new dimension into nicotine and tobacco policy debate, one that extends beyond domestic public health objectives and into the increasingly complex intersection of sovereignty, trade law, and international regulatory coherence. While the immediate issue centers on tobacco…

Nicotine Analogs and the Next Regulatory Frontier: Emerging Questions for Science, Policy, and Product Governance

Inspired by commentary from Chris Allen on discussions surrounding the 10th Keller and Heckman Symposium. As global nicotine regulation continues to evolve, one of the more technically complex and strategically significant emerging issues is the rise of nicotine analogs, compounds structurally related to nicotine that may increasingly challenge existing regulatory definitions, product classifications, and enforcement…

Argentina Rewrites Its Nicotine Policy Framework: From Prohibition to Regulatory Integration

Argentina has formally entered a new era in nicotine product governance. With the publication of Resolution 549/2026, the Ministry of Health has replaced a longstanding prohibition-centered framework with a structured regulatory system for innovative nicotine products (INPs), including vaping products, heated tobacco products, and nicotine pouches. Framed domestically as the “fin de la prohibición,” Argentine…

France’s Nicotine Pouch Ban and Europe’s Regulatory Divide: What It Reveals About EU Policy Fragmentation

France’s recent move to prohibit nicotine pouches has intensified debate across Europe over how emerging nicotine products should be governed within the European Union’s legal and regulatory architecture. The decision has drawn attention not only because of its domestic implications, but because it highlights a broader and increasingly visible challenge within Europe: regulatory fragmentation between…

From Pilot to Precedent: How FDA’s Nicotine Pouch Program May Reshape Premarket Review

Inspired by analysis from Andrew Mooney of Broughton Group and broader discussions emerging from ATNF 2026. The U.S. Food and Drug Administration’s recent nicotine pouch pilot program may prove to be one of the most consequential regulatory developments for reduced-risk nicotine products in years, not because it lowered standards, but because it demonstrated that speed…

Taxation and Market Surveillance: Navigating Policy Complexity in the EU and Beyond

At EVO NXT 2026, the Global Institute for Novel Nicotine hosted a deep dive session examining how taxation frameworks and market surveillance systems are shaping the regulation and development of alternative nicotine products across the EU and beyond. The session was moderated by Ciprian Boboi and featured contributions from Tomasz Płaska, Leonhard Kipphan, and Lorenzo…

GINN Insight: Precaution or Substitution: How Policy Shapes Smoking Decline

Over the last decade, smoking has fallen across most high-income countries, but not at the same pace. In some jurisdictions, the decline has been steep; in others, more gradual and persistent. This variation is not solely explained by cultural or economic factors. It reflects differences in regulatory design and how policymakers approach nicotine use. This…

Global Nicotine Pouch News Monitoring

The nicotine pouch category is evolving rapidly across global markets, driven by regulatory shifts, growing consumer adoption, and strategic investment from major industry players. At GINN, we are building an AI-powered monitoring system designed to track global nicotine and oral product developments with greater speed, accuracy, and relevance. The concept is simple: AI scans hundreds…